Impact of policy change on late-term abortion: a two-decade analysis

• Published in: Archives of gynecology and obstetrics 2024-09, Vol.310 (3), p.1607-1610
• Main Authors: Pekar - Zlotin, Marina, Nehama - Berman, Yael, Melcer, Yaakov, Radinsky, Igal Igor, Maymon, Ron
• Format: Article
• Language: English
• Subjects: Abortion; Abortion, Induced - statistics & numerical data; Adult; Endocrinology; Female; Gestational Age; Gynecology; Health Policy; Human Genetics; Humans; Israel; Maternal-Fetal Medicine; Medicine; Medicine & Public Health; Obstetrics/Perinatology/Midwifery; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies
• ISSN: 1432-0711; 0932-0067; 1432-0711
• DOI: 10.1007/s00404-024-07625-9

Objective Advances in ultrasound and molecular genetics have changed the field of late termination of pregnancy (LTOP), sparking ethical debates worldwide. In 2007, Israel updated its LTOP policies, requiring a 30% or higher probability of severe handicap for approval of LTOP after 24 weeks’ gestation. Purpose In this retrospective study, we compared LTOP indications and approval rates before (Group 1: 1998–2007) and after (Group 2: 2008–2021) this policy change. Methods Shamir medical records from January 1, 1998 to December 31, 2021 were examined and yielded 4047 abortions, of which 248 were identified as LTOP preformed after 24 weeks’ gestation. These cases were then categorized into two groups. Data including maternal age, obstetric history, indications for abortion, diagnosis, week of termination, and genetic/sonographic findings were analyzed. The approval rates and indications pre- and post-policy change were compared. Results Group 1 (LTOP 1998–2007) comprised 95 cases (10.6%), and Group 2 (LTOP 2008–2021) was composed of 153 cases (4.9%). Fetal structural anomalies remained the dominant indication for both groups (67.4 and 65.3%, respectively), with a slight increase in confirmed genetic anomalies from 26.3% (Group 1) to 28% (Group 2). Conclusion Our findings indicate a decrees in the proportion per year from 10.6 to 4.9% LTOP. Technological advances in genetic evaluation and sonography may have contributed to the early increased detection and decrees in cases reaching LTOP. These results highlight the importance of ongoing ethical reviews and adherence to strict protocols for early detection and termination before 24 weeks’ gestation.